The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN – Frontieras North America (“Frontieras” or the “Company”), an energy and environmental ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
HOUSTON, March 10, 2026 (GLOBE NEWSWIRE) -- via IBN – Frontieras North America (“Frontieras” or the “Company”), an energy and environmental technology company commercializing its patented FASForm™ ...
URBANA, Ill. - The U.S. is the world's largest producer of bioethanol as renewable liquid fuel, with more than 200 commercial plants processing over 16 billion gallons per year. Plants typically use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results